Surveillance policy for Japanese patients with stage I testicular germ cell cancer in the multi-detector computed tomography era
暂无分享,去创建一个
Y. Ishikawa | Hajime Tanaka | Y. Fujii | S. Urakami | N. Inoshita | Shinya Yamamoto | J. Yonese | H. Masuda | I. Fukui | T. Yuasa
[1] A. Wein,et al. Campbell-Walsh Urology , 2011 .
[2] A. Horwich,et al. EAU guidelines on testicular cancer: 2011 update. , 2011, European urology.
[3] G. Duncan,et al. Evolution in management of testicular seminoma: population-based outcomes with selective utilization of active therapies. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.
[4] G. Pond,et al. Non-risk-adapted surveillance in clinical stage I nonseminomatous germ cell tumors: the Princess Margaret Hospital's experience. , 2011, European urology.
[5] G. Rustin,et al. Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214). , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] Y. Miyasaka,et al. A study of the assessment of axillary lymph nodes before surgery for breast cancer using multidetector-row computed tomography , 2010, Surgery Today.
[7] R. Bremnes,et al. Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[8] M. Gleave,et al. Non-risk-adapted surveillance for patients with stage I nonseminomatous testicular germ-cell tumors: diminishing treatment-related morbidity while maintaining efficacy. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[9] M. Jewett,et al. Surveillance in stage I nonseminomatous germ cell tumours of the testis , 2009, BJU international.
[10] I. Narabayashi,et al. Preoperative Evaluation of Local Invasion and Metastatic Lymph Nodes of Colorectal Cancer and Mesenteric Vascular Variations Using Multidetector-Row Computed Tomography Before Laparoscopic Surgery , 2007, Journal of computer assisted tomography.
[11] L. Paz-Ares,et al. Multicentre risk-adapted management for stage I non-seminomatous germ cell tumours. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.
[12] M. Urashima,et al. Clinical value of multidetector row computed tomography in detecting lymph node metastasis of early gastric cancer. , 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[13] M. Mason,et al. Treatment of testicular germ-cell cancer: a cochrane evidence-based systematic review. , 2002, Cancer treatment reviews.
[14] F. Algaba,et al. EAU Guidelines on Testicular Cancer , 2001, European Urology.
[15] N. Summers,et al. Compliance of clinical stage I nonseminomatous germ cell tumor patients with surveillance. , 1998, The Journal of urology.
[16] M. Williams,et al. Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] E. Paus,et al. Early clinical stages (CS1, CS1Mk+ and CS2A) of non-seminomatous testis cancer. Value of pre- and post-orchiectomy serum tumor marker information in prediction of retroperitoneal lymph node metastases. Swedish-Norwegian Testicular Cancer Project (SWENOTECA). , 1990, Annals of oncology : official journal of the European Society for Medical Oncology.
[18] T. Gilligan,et al. Neoplasms of the Testis , 2012 .
[19] L. Mazzucchelli,et al. Adjuvant chemotherapy after orchiectomy in high-risk patients with clinical stage I non-seminomatous testicular cancer. , 1993, European urology.